Changes in Osteoblastic Activity in Patient Who Received Bortezomib as Second Line Treatment for Plasma Cell Myeloma: A Prospective Multicenter Study
- 期刊名称BioMed Research International
- 作者Eom, Ki-Seong; Kim, Seok Jin; Lee, Je-Jung; Suh, Cheolwon; Kim, Jin Seok; Yoon, Sung-Soo; Kim, Byung Soo; Kang, Hye Jin; Choi, Young Jin; Kim, Chul Soo; Kim, Yang Soo; Kwak, Jae-Yong; Kim, Yoo Jin; Joo, Young Don; Mun, Yeung-Chul; Jo, Deog Yeon; Park, Joon Seong; Park, Chi-Young; Kim, Sung-Hyun; Min, Chang-Ki
- 卷第2014卷
- 印刷ISSN2314-6133
- 电子ISSN2314-6141
- 文件大小227.31KB
- 发表时间2014
- DOI10.1155/2014/245247
- 页码1-7
Pathophysiological Significance of Hepatic ApoptosisWang, Kewei; Lin, Bingliang · ISRN Hepatology · 2013
Mild Hypertransaminasemia in Primary CareAl-Busafi, Said A.; Hilzenrat, Nir · ISRN Hepatology · 2013
Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological PerspectivesMacias, Rocio I. R. · ISRN Hepatology · 2014
The Evolution of Transjugular Intrahepatic Portosystemic Shunt: TipsFanelli, Fabrizio · ISRN Hepatology · 2014
Gastrointestinal Bleeding in Cirrhotic Patients with Portal HypertensionBiecker, Erwin · ISRN Hepatology · 2013
Hepatic Encephalopathy: From the Pathogenesis to the New TreatmentsCordoba, Juan · ISRN Hepatology · 2014
Murine Models of Nonalcoholic Fatty Liver Disease and SteatohepatitisNinomiya, Masashi; Kondo, Yasuteru; Shimosegawa, Tooru · ISRN Hepatology · 2013